NCT03413761View on ClinicalTrials.gov

Antioxidant Supplements, Genetics and Chemotherapy Outcomes

CompletedOBSERVATIONAL

Enrollment

1,771

Participants

Timeline

Start Date

December 18, 2004

Primary Completion Date

November 12, 2013

Study Completion Date

November 12, 2013

Conditions

Node Positive Breast CancerNode Negative Breast Cancer

All Listed Sponsors

lead

Roswell Park Cancer Institute

OTHER

NCT03413761 - Antioxidant Supplements, Genetics and Chemotherapy Outcomes | Biotech Hunter | Biotech Hunter